Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Continuous Glucose Monitoring Technologies
  • CME
  • CE

Credits Available
Physicians: maximum of 0.5 AMA PRA Category 1 Credits
Registered Nurses: 0.5 Nursing contact hours
Pharmacists: 0.5 contact hours (0.05 CEUs)
Registered Dieticians/Dietetic Technicians, Registered: maximum of 0.5 CPEU(s)
Released: July 7, 2021 Expiration: July 6, 2022
Start Activity
Provided by the Endocrine Society in collaboration with the ADCES

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

 

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Abbott Diabetes
Medtronic
Novo Nordisk Inc.
Ananda Basu, MD, FRCP
Program Director
Elyse Marriner, BSN, RN, CDCES

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Appraise glucose sensing and insulin dosing guidance technologies to improve and maintain glycemic control
  • Identify methods to overcome clinician, system, and patient barriers to successful adoption of diabetes smart technologies
  • Outline a team-based approach to initiation and utilization of smart diabetes technologies in practice

Information on this Educational Activity

STATEMENT OF INDEPENDENCE

As a provider of continuing medical education (CME) accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The commercial supporters of this activity have no influence over the planning of this CME activity.

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

Program Director

Ananda Basu, MD, FRCP

Harrison Professor of Medicine
Division of Endocrinology
Department of Medicine
University of Virginia
Charlottesville, Virginia

Ananda Basu, MD, has no disclosures to report.

Faculty

Elyse Marriner, BSN, RN, CDCES

Registered Nurse
Endocrinology Pantops
University Physicians Group
Charlottesville, Virginia

Elyse Marriner, BSN, RN, CDCES, has no disclosures to report.

Staff

Susan Daniels, PhD
Scientific Director
Susan Daniels, PhD, has no relevant conflicts of interest to report.
Kiran D. Mir-Hudgeons, PhD

Manager, Editorial Operations

Kiran Mir-Hudgeons, PhD, has no relevant conflicts of interest to report.
Jodi Lavin-Tompkins, MSN, RN, BC-ADM, CDCES

Director of Accreditation/Content Development
Association of Diabetes Care & Education Specialists

Jodi Lavin-Tompkins MSN, RN, BC-ADM, CDCES, has no relevant conflicts of interest to report.
Ruth Cohen Cooper, CHCP

Vice President, Science and Strategy

Ruth Cohen Cooper, CHCP, has no relevant conflicts of interest to report.
Joanne Rinker, MS, RDN, CDCES, LDN, FADCES

Senior Director of Practice
Content and Learning
Association of Diabetes Care & Education Specialists

Joanne Rinker MS, RDN, CDCES, LDN, FADCES, has no relevant conflicts of interest to report.

DISCLAIMERS

The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.

Use of professional judgment:
The educational content in this activity relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.

Drugs and dosages:
When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

POLICY ON UNLABELED/OFF-LABEL USE

The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such off-label use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

Target Audience

Clinicians who are involved in the care patients with diabetes including those who specialize in endocrinology, internal medicine and family medicine (physicians, nurses, PAs, nurse practitioners, dietitians, diabetes care and education specialists) advanced practice providers, certified diabetes educators), pharmacists, patients and caregivers.

Goal

The goal of the curriculum is to optimize the utilization of advanced continuous glucose monitoring (CGM) and drug administration technologies to promote improved glycemic control, prevent and slow the onset and progression of diabetes related complications, and enhance patient education and adherence.

Physician Continuing Medical Education

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit

The Endocrine Society designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

 In support of improving patient care, this activity has been planned by Endocrine Society and Clinical Care Options and the Association of Diabetes Care & Education Specialists. Association of Diabetes Care & Education Specialists is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

American Nurses Credentialing Center (ANCC)

The Association of Diabetes Care & Education Specialists designates this activity for a maximum of 0.5 ANCC contact hours.

The Association of Diabetes Care & Education Specialists is approved by the California Board of Registered Nursing, Provider Number 10977, for 0.5 contact hours.

Accreditation Council for Pharmacy Education

The Universal Activity Number is JA4008258-9999-21-505-H01-P. This knowledge-based activity has been approved for 0.5 contact hour(s).

Registered Dietitians/Dietetic Technicians, Registered

Commission on Dietetic Registration (CDR)

CDR Credentialed Practitioners will receive 0.5 Continuing Professional Education units (CPEUs) for completion of this activity. Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1 CPEU. RDs and DTRs are to select activity type 102 in their Activity Log. Performance Indicator selection is at the learner’s discretion.

Certified Diabetes Care and Education Specialists: To satisfy the requirements for renewal of certification for the Certification Board for Diabetes Care and Education (CBDCE), continuing education activities must be diabetes related and approved by a provider on the CBDCE list of Approved Providers (www.ncbde.org). CBDCE does not approve continuing education. The Association of Diabetes Care & Education Specialists is on the CBDCE list of Approved Providers.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from July 07, 2021, through July 06, 2022:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Continuous Glucose Monitoring Technologies
  • CME
  • CE

Loading...
Learn how to optimize outcomes in persons with diabetes using continuous glucose monitoring.
Ananda Basu, MD, FRCP
Program Director
Elyse Marriner, BSN, RN, CDCES
Physicians: maximum of 0.5 AMA PRA Category 1 Credits
Registered Nurses: 0.5 Nursing contact hours
Pharmacists: 0.5 contact hours (0.05 CEUs)
Registered Dieticians/Dietetic Technicians, Registered: maximum of 0.5 CPEU(s)
Released: July 7, 2021 Expiration: July 6, 2022

Related Content

From Dr. Carol Hatch Wysham and Clinical Care Options (CCO), expert commentary on improving care for type 2 diabetes

Carol Hatch Wysham, MD Released: October 7, 2021

Downloadable slides from Clinical Care Options (CCO) featuring expert insights on individualizing management of patients with T2D and cardiometabolic comorbidities

Carol Hatch Wysham, MD Released: September 30, 2021

Short video from Clinical Care Options (CCO) featuring expert insights on the clinical management of persons with T2D and metabolic comorbidities

Carol Hatch Wysham, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Registered Dieticians/Dietetic Technicians, Registered: maximum of 0.5 CPEU(s) Released: September 30, 2021 Expired: September 29, 2022

From Dr. Carol Hatch Wysham and Clinical Care Options (CCO), expert commentary on emerging data on tirzepatide for type 2 diabetes

Carol Hatch Wysham, MD Released: September 21, 2021
Provided by the Endocrine Society in collaboration with the ADCES

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

 

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Abbott Diabetes
Medtronic
Novo Nordisk Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue